Log in

NYSE:USPH - U.S. Physical Therapy Stock Price, Forecast & News

$120.94
-0.13 (-0.11 %)
(As of 01/21/2020 07:25 AM ET)
Today's Range
$119.53
Now: $120.94
$122.09
50-Day Range
$112.94
MA: $116.04
$121.39
52-Week Range
$102.92
Now: $120.94
$148.48
Volume57,541 shs
Average Volume77,488 shs
Market Capitalization$1.54 billion
P/E Ratio51.91
Dividend Yield0.99%
Beta1.03
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors As of March 14, 2019, it operated 592 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. Read More…

Industry, Sector and Symbol

Industry Health services
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP90337L10
Phone713-297-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$453.91 million
Cash Flow$3.41 per share
Book Value$17.10 per share

Profitability

Net Income$34.87 million

Miscellaneous

Employees4,600
Market Cap$1.54 billion
Next Earnings Date3/5/2020 (Estimated)
OptionableOptionable

Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter.


U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Thursday, November 7th. Shareholders of record on Monday, November 18th will be given a dividend of $0.30 per share on Friday, December 13th. This represents a $1.20 dividend on an annualized basis and a yield of 0.99%. The ex-dividend date is Friday, November 15th. View U.S. Physical Therapy's Dividend History.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) released its earnings results on Thursday, November, 7th. The company reported $0.71 earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of $0.71. The company earned $117.30 million during the quarter, compared to the consensus estimate of $121.28 million. U.S. Physical Therapy had a return on equity of 16.57% and a net margin of 6.36%. The firm's revenue was up 3.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.64 EPS. View U.S. Physical Therapy's Earnings History.

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for U.S. Physical Therapy.

What guidance has U.S. Physical Therapy issued on next quarter's earnings?

U.S. Physical Therapy issued an update on its FY 2019 Pre-Market earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of $2.80-2.90 for the period, compared to the Thomson Reuters consensus estimate of $2.94.

What price target have analysts set for USPH?

2 equities research analysts have issued 1 year target prices for U.S. Physical Therapy's shares. Their forecasts range from $106.61 to $130.00. On average, they expect U.S. Physical Therapy's share price to reach $118.31 in the next twelve months. This suggests that the stock has a possible downside of 2.2%. View Analyst Price Targets for U.S. Physical Therapy.

What is the consensus analysts' recommendation for U.S. Physical Therapy?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for U.S. Physical Therapy.

Has U.S. Physical Therapy been receiving favorable news coverage?

News coverage about USPH stock has been trending extremely negative recently, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. U.S. Physical Therapy earned a coverage optimism score of -4.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for U.S. Physical Therapy.

Are investors shorting U.S. Physical Therapy?

U.S. Physical Therapy saw a decrease in short interest during the month of December. As of December 31st, there was short interest totalling 994,500 shares, a decrease of 7.1% from the December 15th total of 1,070,000 shares. Based on an average trading volume of 101,900 shares, the days-to-cover ratio is currently 9.8 days. Approximately 7.9% of the shares of the stock are short sold. View U.S. Physical Therapy's Current Options Chain.

Who are some of U.S. Physical Therapy's key competitors?

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), Gilead Sciences (GILD), AbbVie (ABBV), Allergan (AGN), Marathon Petroleum (MPC), UnitedHealth Group (UNH), Cisco Systems (CSCO), PepsiCo (PEP), Starbucks (SBUX) and Walgreens Boots Alliance (WBA).

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the folowing people:
  • Mr. Christopher J. Reading, Pres, CEO & Director (Age 55)
  • Mr. Lawrance W. McAfee, Exec. VP, CFO & Director (Age 64)
  • Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 62)
  • Mr. Graham Reeve M.B.A., P.T., Chief Operating Officer of East (Age 55)
  • Mr. Jon C. Bates, VP & Corp. Controller

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (2.92%), Boston Trust Walden Corp (0.94%), Scout Investments Inc. (0.75%), State of Alaska Department of Revenue (0.08%), Louisiana State Employees Retirement System (0.03%) and We Are One Seven LLC (0.02%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Jerald L Pullins, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson. View Institutional Ownership Trends for U.S. Physical Therapy.

Which major investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Scout Investments Inc., AE Wealth Management LLC, Louisiana State Employees Retirement System, State of Alaska Department of Revenue and We Are One Seven LLC. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Lawrance W Mcafee and Mark J Brookner. View Insider Buying and Selling for U.S. Physical Therapy.

Which major investors are buying U.S. Physical Therapy stock?

USPH stock was bought by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin and Regg E Swanson. View Insider Buying and Selling for U.S. Physical Therapy.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $120.94.

How big of a company is U.S. Physical Therapy?

U.S. Physical Therapy has a market capitalization of $1.54 billion and generates $453.91 million in revenue each year. The company earns $34.87 million in net income (profit) each year or $2.65 on an earnings per share basis. U.S. Physical Therapy employs 4,600 workers across the globe.View Additional Information About U.S. Physical Therapy.

What is U.S. Physical Therapy's official website?

The official website for U.S. Physical Therapy is http://www.usph.com/.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]


MarketBeat Community Rating for U.S. Physical Therapy (NYSE USPH)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  201 (Vote Outperform)
Underperform Votes:  299 (Vote Underperform)
Total Votes:  500
MarketBeat's community ratings are surveys of what our community members think about U.S. Physical Therapy and other stocks. Vote "Outperform" if you believe USPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel